DK1963295T3 - 3,6-dihydro-2-oxo-6H-(1,3,4)thiazinderivater - Google Patents

3,6-dihydro-2-oxo-6H-(1,3,4)thiazinderivater

Info

Publication number
DK1963295T3
DK1963295T3 DK06818286.4T DK06818286T DK1963295T3 DK 1963295 T3 DK1963295 T3 DK 1963295T3 DK 06818286 T DK06818286 T DK 06818286T DK 1963295 T3 DK1963295 T3 DK 1963295T3
Authority
DK
Denmark
Prior art keywords
dihydro
oxo
thiazine derivatives
thiazine
derivatives
Prior art date
Application number
DK06818286.4T
Other languages
English (en)
Inventor
Oliver Schadt
Dieter Dorsch
Melanie Schultz
Andree Blaukat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1963295T3 publication Critical patent/DK1963295T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK06818286.4T 2005-11-21 2006-10-25 3,6-dihydro-2-oxo-6H-(1,3,4)thiazinderivater DK1963295T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005055355A DE102005055355A1 (de) 2005-11-21 2005-11-21 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate
PCT/EP2006/010286 WO2007057093A1 (de) 2005-11-21 2006-10-25 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate

Publications (1)

Publication Number Publication Date
DK1963295T3 true DK1963295T3 (da) 2011-09-26

Family

ID=37758761

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06818286.4T DK1963295T3 (da) 2005-11-21 2006-10-25 3,6-dihydro-2-oxo-6H-(1,3,4)thiazinderivater

Country Status (21)

Country Link
US (1) US7534785B2 (da)
EP (1) EP1963295B1 (da)
JP (1) JP5227179B2 (da)
KR (1) KR101424826B1 (da)
CN (1) CN101312958A (da)
AR (1) AR057899A1 (da)
AT (1) ATE518848T1 (da)
AU (1) AU2006314874B2 (da)
BR (1) BRPI0618822A2 (da)
CA (1) CA2630203C (da)
CY (1) CY1112235T1 (da)
DE (1) DE102005055355A1 (da)
DK (1) DK1963295T3 (da)
EA (1) EA015253B1 (da)
ES (1) ES2367586T3 (da)
IL (1) IL191361A (da)
PL (1) PL1963295T3 (da)
PT (1) PT1963295E (da)
SI (1) SI1963295T1 (da)
WO (1) WO2007057093A1 (da)
ZA (1) ZA200805404B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005055354A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine
DE102007026341A1 (de) * 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
DE102007032507A1 (de) 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
DE102007041115A1 (de) 2007-08-30 2009-03-05 Merck Patent Gmbh Thiadiazinonderivate
DE102007061963A1 (de) * 2007-12-21 2009-06-25 Merck Patent Gmbh Pyridazinonderivate
DE102008062826A1 (de) 2008-12-23 2010-07-01 Merck Patent Gmbh Pyridazinonderivate
GB201713962D0 (en) * 2017-08-31 2017-10-18 Ctxt Pty Ltd Compounds
GB201810092D0 (en) 2018-06-20 2018-08-08 Ctxt Pty Ltd Compounds
GB201810581D0 (en) 2018-06-28 2018-08-15 Ctxt Pty Ltd Compounds
KR102823056B1 (ko) 2019-06-18 2025-06-23 화이자 인코포레이티드 벤즈이속사졸 설폰아마이드 유도체
CN111454232B (zh) * 2020-05-30 2021-11-23 南方医科大学 一种1,3,4-噻二嗪类化合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502699A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
DE19604388A1 (de) * 1996-02-07 1997-08-14 Merck Patent Gmbh Arylalkyl-diazinone
DE10150517A1 (de) * 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
EP1463509A1 (en) * 2001-10-31 2004-10-06 MERCK PATENT GmbH Type 4 phosphodiesterase inhibitors and uses thereof
DE102005055354A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine

Also Published As

Publication number Publication date
ES2367586T3 (es) 2011-11-04
CN101312958A (zh) 2008-11-26
EA015253B1 (ru) 2011-06-30
PL1963295T3 (pl) 2011-11-30
SI1963295T1 (sl) 2011-09-30
CA2630203A1 (en) 2007-05-24
IL191361A (en) 2013-11-28
DE102005055355A1 (de) 2007-10-31
ZA200805404B (en) 2009-11-25
CA2630203C (en) 2015-01-27
AU2006314874A1 (en) 2007-05-24
ATE518848T1 (de) 2011-08-15
EP1963295A1 (de) 2008-09-03
AR057899A1 (es) 2007-12-26
US20080306052A1 (en) 2008-12-11
US7534785B2 (en) 2009-05-19
BRPI0618822A2 (pt) 2011-09-13
PT1963295E (pt) 2011-11-15
CY1112235T1 (el) 2015-12-09
WO2007057093A1 (de) 2007-05-24
KR20080070768A (ko) 2008-07-30
KR101424826B1 (ko) 2014-08-01
JP5227179B2 (ja) 2013-07-03
AU2006314874B2 (en) 2012-01-19
EA200801366A1 (ru) 2008-10-30
EP1963295B1 (de) 2011-08-03
JP2009516658A (ja) 2009-04-23

Similar Documents

Publication Publication Date Title
HUS1900034I1 (hu) 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok
NL300935I2 (nl) guselkumab.
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
ATE481383T1 (de) 3-aza-bicycloä3.1.0ühexanderivate
ATE469145T1 (de) 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-
DE602007001681D1 (de) 1,3-dioxan-carboxylsäuren
ATE506362T1 (de) 1-aza-bicycloä3.3.1ünonane
NO20051199L (no) Rorhandteringsutstyr.
ZA200805404B (en) 3,-6-Dihydro-2-oxo-6H-(1,3,4) thiadiazine derivatives
FI20030261A0 (fi) Iskulaite
NL2000937A1 (nl) Piperidinederivaten.
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1951697T3 (da) Substitueret 5-phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazin
DK1971588T3 (da) Tiglien-3-onderivater
NO20053362D0 (no) Syklofuge.
DE602006014973D1 (de) Neuartige cercosporamidderivate
ATE541837T1 (de) Oxaphenanthren-derivate
EP1940415A4 (en) 19,23,24,25,26,27-HEXANOR-1ALPHA-HYDROXYVITAMINE D3
DE602006019209D1 (de) Fluoroalkylpyrrolidin-derivate
ITPG20050014A1 (it) Cosmeticus bibbia n.3
ITLC20040002A1 (it) P.p.0
ES1055975Y (es) Ambientador perfeccionado.
ATE471314T1 (de) Neuartige cercosporamidderivate